Startseite Crystal structure of 2-[(2-oxo-thiazolidine-3-carbonyl)sulfamoyl]-methy-benzoic acid methyl ester, C13H14N2O6S2
Artikel Open Access

Crystal structure of 2-[(2-oxo-thiazolidine-3-carbonyl)sulfamoyl]-methy-benzoic acid methyl ester, C13H14N2O6S2

  • Qing-Wu Chen EMAIL logo und De-Long Shen
Veröffentlicht/Copyright: 14. Oktober 2016

Abstract

C13H14N2O6S2, monoclinic, C2/c (no. 15), a = 28.1174(10)Å, b = 9.8677(4)Å, c = 11.2738(4)Å, β = 98.4457(11)°, V = 3094.0(2)Å3, Z = 8, Rgt(F) = 0.0382, wRref(F2) = 0.1141, T = 296(2) K.

CCDC no.:: 1506293

The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block

Size 0.28 × 0.17 × 0.10 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:3.8 cm−1
Diffractometer, scan mode:Rigaku RAXIS-RAPID, ω-scans
2θmax, completeness:54.8°, >99%
N(hkl)measured, N(hkl)unique, Rint:14936, 3529, 0.050
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2326
N(param)refined:210
Programs:SHELX [7], CrystalClear [8]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
S10.38056(2)0.58058(6)0.71532(5)0.04198(18)
S20.21754(3)0.62282(8)0.28584(8)0.0711(3)
C10.34043(8)0.6800(2)0.5013(2)0.0403(5)
O20.35616(6)0.50676(18)0.79716(14)0.0520(4)
N20.29830(6)0.68091(19)0.41667(17)0.0409(4)
N10.33947(7)0.58930(19)0.59385(17)0.0438(5)
H10.31590.53310.58830.053*
O30.37315(6)0.75475(18)0.49105(15)0.0534(4)
O40.25432(7)0.5098(2)0.48893(18)0.0636(5)
C40.25991(9)0.5947(3)0.4137(2)0.0473(6)
O50.46193(7)0.39568(19)0.90780(17)0.0632(5)
O10.39832(7)0.71296(17)0.74628(15)0.0550(5)
O60.47368(6)0.17356(19)0.93706(16)0.0604(5)
C60.41671(8)0.3334(2)0.6607(2)0.0431(5)
C100.41887(9)0.1029(2)0.7323(2)0.0538(6)
H100.42810.04010.79290.065*
C120.45661(8)0.2809(3)0.8724(2)0.0455(6)
C110.43044(8)0.2389(2)0.7525(2)0.0412(5)
C50.42798(8)0.4825(2)0.6710(2)0.0474(6)
H5A0.43480.51540.59410.057*
H5B0.45670.49530.72900.057*
C20.29779(10)0.7727(3)0.3141(2)0.0578(7)
H2A0.32600.75730.27560.069*
H2B0.29820.86610.34100.069*
C70.39179(10)0.2869(3)0.5528(2)0.0596(7)
H70.38250.34820.49110.072*
C80.38054(12)0.1516(3)0.5354(3)0.0734(9)
H80.36360.12290.46260.088*
C130.49567(11)0.1999(4)1.0589(3)0.0777(9)
H13A0.51820.27321.05960.116*
H13B0.51220.12011.09160.116*
H13C0.47130.22391.10640.116*
C90.39415(11)0.0591(3)0.6246(3)0.0683(8)
H90.3868−0.03220.61260.082*
C30.25320(13)0.7463(4)0.2273(3)0.0856(10)
H3A0.26180.71480.15180.103*
H3B0.23500.82960.21220.103*

Source of material

2-Isocyanatosulfonylmethyl-benzoic acid methyl ester (2.55 g, 0.01 mol), 2-thiazolidione (1.03 g, 0.01 mol) and anhydrous methylene chloride (50 mL) were added into a three-necked flask. After stirring at ambient temperature for sixteen hours the solvent was removed under reduced pressure. The residue was purified by column chromatography on silica gel using petroleum ether/acetone (1:2 v/v) as the eluent, giving a light yellow solid (yield 85%). m.p.: 132-134 °C. IR(KBr): 3168 (N—H); 1743 (C = O); 1382, 1353, 1196 (O = S=O) cm−1; 1H NMR (TMS, CDCl3): δ 3.35(t, 2H, CH2), 3.93(s, 3H, OCH3), 4.26(t, 2H, CH2), 5.35(s, 2H, CH2), 7.44–7.54(m, 3H, ArH), 7.96–7.98 (t, H, ArH), 10.26(s, H, NH). Elemental Anal. Calcd. (%): C, 43.57; H, 3.94; N, 7.82. Found(%): C, 43.65; H, 4.01; N, 7.71.

Experimental details

The structure was solved by direct methods and successive Fourier difference synthesis [7], [8]. H atoms were positioned geometrically and refined using a riding model [aliphatic C—H = 0.97(2) Å and N—H = 0.86 Å, Uiso(H) = 1.2Ueq(C)].

Discussion

Many scientists have been devoted to study pesticides which have ultra-low application rates and extremely low mammal toxicity. Since chlorsulfuron, a sulfonylureas herbicide, was found in 1982, various novel sulfonylurea herbicides [1] have been found and commercialized, such as Chlorimuron-ethyl, primisulfuron, Monosulfuron and foramsulfuron. Synthesis of a broader spectrum and highly biological sulfonylurea compounds became a hot spot. In view of these facts, and as a part of our work on the synthesis of bioactive lead compounds for drug discover [2], the title compounds were designed by introducing a 2-thiazolidione pharmacophore into sulfonylurea scaffold. A new sulfonylurea derivative containing 2-thiazolidione had been synthesized by the reaction of 2-thiazolidiones and 2-isocyanatosulfonylmethyl-benzoic acid methyl ester.

In the crystal structure, the bond length of N(1)—S(1) 1.6592(19) Å is shorter than S(1)—C(5) 1.777(2) Å and S(1)—C(5) 1.766(4) Å the bond lengths of N1—C1 and N2—C4 are 1.378(3) and 1.371(3) respectively. The torsion angle of thioether group C5—S1—N1—C1 is -82.4(2)°. In the aromatic rings, the molecular dimensions are as expected with the aromatic C—C bond distances between 1.371(4) and 1.405(3) Å. The aromatic C—C—C bond angles ranging from 118.3(2) to 121.5(3)o are almost within the normal ranges [3].

There exist no classical hydrogen bonds in the molecule. The herbicidal, fungicidal, insecticidal activities of the title compound were measured according to the reference method [4], [5], [6]. The results indicated that the title compound showed weak inhibitory activity against Fusarium oxysporum, Rhizoctonia solani, Gibberella zeae, Botryospuaeria berengeriana and Colletotrichum gossypii at 50 ppm, respectively. The title compound exhibited moderate insecticidal activity (48.1%) against aphid. For the herbicidal activity, the compound displayed moderate activity against the root of Brassica napus and Echinochloa crusgalli at 100 ppm, but it showed weak inhibitory at 10 ppm.

References

1. Guo, W. C.; Tan, H. Z.; Liu, X. H.; Li, Y. H.; Wang, S. H.; Li, Z. M.: Synthesis and biological activity of new trisubstituted pyrimidine phenylsulfonylurea derivatives. Chem. J. Chinese U. 29 (2008) 319–323.Suche in Google Scholar

2. Liu, X. H.; Zhai, Z. W.; Xu, X. Y.; Yang, M. Y.; Sun, Z. H.; Weng, J. Q.; Tan, C. X.; Chen, J.: Facile and efficient synthesis and biological activity determination of novel 1,2,4-triazolo[4,3-a]pyridin-3(2H)-one derivatives via microwave irradiation. Bioorg. Med. Chem. Lett. 25 (2015) 5524–5528.10.1016/j.bmcl.2015.10.064Suche in Google Scholar PubMed

3. Chen, P.Q.; Tan, C.X.; Weng, J.Q.; Liu, X.H. Synthesis, Structure and DFT Calculation of Chlorimuron-ethyl. Asian J. Chem. 24 (2012), 2808–2810.Suche in Google Scholar

4. Zhang, L. J.; Yang, M. Y.; Sun, Z. H.; Tan, C. X.; Weng, J. Q.; Wu, H. K.; Liu, X. H.: Synthesis and antifungal activity of 1,3,4-thiadiazole derivatives containing pyridine group. Lett. Drug Des. Discov. 11 (2014) 1107–1111.10.2174/1570180811666140610212731Suche in Google Scholar

5. Liu, X. H.; Xu, X. Y.; Tan, C. X.; Weng, J. Q.; Xin, J. H.; Chen, J.: Synthesis, crystal structure, herbicidal activities and 3D-QSAR study of some novel 1,2,4-triazolo[4,3-a]pyridine derivatives. Pest. Manag. Sci. 71 (2015) 292–301.10.1002/ps.3804Suche in Google Scholar PubMed

6. Mao, M. Z.; Li, Y. X.; Liu, Q. X.; Xiong, L. X.; Zhang, X.; Li, Z. M.: Synthesis and biological evaluation of novel N-pyridylpyrazole derivatives containing 1,2,3-triazole moieties. J. Pestic. Sci. 40 (2015) 138–142.10.1584/jpestics.D15-020Suche in Google Scholar

7. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

8. Rigaku/MSC. CrystalClear. Rigaku/MSC Inc., The Woodlands, Texas, USA, (2006).Suche in Google Scholar

Received: 2016-5-7
Accepted: 2016-9-26
Published Online: 2016-10-14
Published in Print: 2017-1-1

©2016 Qing-Wu Chen et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Editorial
  3. Twenty years of crystal structure publication and the road ahead
  4. Crystal Structures
  5. Crystal structure of poly-[triaqua-(μ4-5′-carboxy-[1,1′-biphenyl]-2,3,3′-tricarboxylate-κ6O1,O2:O3,O4:O5:O6)praseodymium(III), C16H13O11Pr
  6. Crystal structure of (R)-1-(2,3-dihydro-1H-pyrrolizin-5-yl)-2,3-dihydroxypropan-1-one, C10H13NO3
  7. Crystal structure of (E)-4-nitro-2-((2-phenoxyphenylimino)methyl)phenol, C19H14N2O4
  8. Crystal structure of 3,3′-di(furan-2-yl)-5,5′-bi-1,2,4-triazine
  9. Crystal structure of 11-(p-coumaroyloxy)-tremetone, C22H20O5
  10. The crystal structure of 1,3-bis(2,6-diiso-propylphenyl)imidazol-2-ylidene)-dibromido-(1-methyl-1H-imidazole-κ1N)palladium(II) – ethyl acetate – water (1/1/1), C31H42Br2N4Pd
  11. Crystal structure of 2-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1H-indene-1,3(2H)-dione, C28H19N5O2
  12. Crystal structure of 2-(5-(4-fluorophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)-4-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)thiazole, C29H25FN6S
  13. Crystal structure of poly-[aqua-(μ7-benzene-1,3,5-tricarboxylato)-(μ3-1,2,4-triazol-1-ido)dicobalt(II)], C11H7Co2N3O7
  14. Crystal constructure of 16(S)-methyl-6α-carboxy-1, 15-dioxo-6, 7-seco-ent-kaur-2-en-7, 20-olide, C20H24O6
  15. Crystal structure of 1-(benzo[d]thiazol-2-yl)-3-phenylthiourea, C14H11N3S2
  16. Crystal structure of 3-(2-bromophenyl)-1,1-dimethylthiourea, C9H11BrN2S
  17. Crystal structure of 1-(adamantan-1-yl)-3-(3-chlorophenyl)thiourea, C17H21ClN2S
  18. Crystal structure of 3-(adamantan-1-yl)-1-(4-bromophenyl)urea, C17H21BrN2O
  19. Crystal structure of (Z)-Ethyl 2-cyano-2-(3-phenylthiazolidin-2-ylidene) acetate, C14H14N2O2S
  20. Crystal structure of methyl 2b-ethyl-1a,2a,2b,2b1,3,5,10,11-octahydro-1H-oxireno[2′,3′:6,7]indolizino[8,1-cd]carbazole-4-carboxylate, C21H24N2O3
  21. Crystal structure of 2-amino-5-oxo-4-(3,4,5-trimethoxy-phenyl)-4,5,6,7-tetrahydro-cyclopenta[b]pyran-3-carbonitrile, C18H18N2O5
  22. Crystal structure of 1,2,3-trimethyl-2,3-dihydro-1H-perimidine, C14H16N2
  23. Crystal structure of bis(2,6-dihydroxymethyl)pyridine-κ3N,O,O′)-bis(μ2-6-chloropyridin-2-olato-κ3N,O:O)-bis(6-chloropyridin-2-olato-κO)-bis(nitrato-κ2O,O′)digadolinium(III), C34H30Cl4Gd2N8O14
  24. Crystal structure of 8-isopropyl-8-aza-bicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate, C19H27NO3
  25. Crystal structure of 1-methyl-3-[((naphthalen-2-ylsulfonyl)oxy)imino]indolin-2-one, C19H14N2O4S
  26. Crystal structure (7,8-bis(diisopropylphosphino)-7,8-dicarba-nido-undecaborane-κ2P,P′)-(benzoato-κ2O,O′)nickel(II), C21H42B9NiO2P2
  27. Crystal structure of methyl-2-methyl-4-(2-oxo-2-phenylethyl)-5-phenyl-1H-pyrrole-3-carboxylate, C21H19NO3
  28. Crystal structure of 2-[(2-oxo-thiazolidine-3-carbonyl)sulfamoyl]-methy-benzoic acid methyl ester, C13H14N2O6S2
  29. Crystal structure of N′-(2-phenylacetyl)thiophene-2-carbohydrazide monohydrate, C13H14N2O3S
  30. Crystal structure of 1,1′-(hexane-1,6-diyl)bis(3-methyl-1H-imidazol-3-ium) bis(hexafluoro phosphate), C14H24F12N4P2
  31. Crystal structure of di-μ-chlorido-bis[1,2-bis(dicyclohexylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]zinc(II), C52H108B20Cl2P4Zn2
  32. Crystal structure of dibromido-bis[μ-1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole-κN]mercury(II), C30H26Br2HgN10
  33. Crystal structure of bis(μ-nitrato-κ2O:O)-bis[1,2-bis(diphenylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]disilver(I) dicloromethane monosolvate, C54H64B20Cl4O6P4Ag2
  34. Crystal structure of dinuclear dichloridobis(dimethylformamide-kO)bis[μ2-3-(2-oxyphenyl)-5-(pyrazin-2-yl)-1,2,4-triazol-1ido-κ4-O,N:N′,N′′(2)]diiron(III) dimethylformamide (1/1), C36H42Cl2Fe2N14O6
  35. Crystal structure of diaqua-dinitrato-κO-bis(4-(1H-pyrazol-3-yl)pyridine-κN)manganese(II), C16H18MnN8O8
  36. Crystal structure of (Z)-6-methoxy-2-(2,2,2-trifluoro-1-hydroxyethylidene)-2,3-dihydro-1H-inden-1-one, C12H6F6O3
  37. Crystal Structure of 4-(2-chloroacetamido)pyridinium chloride monohydrate, C7H10Cl2N2O2
  38. Crystal structure of 2-amino-4-(4-chloro-phenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13ClN2O2
  39. Crystal structure of (E)-1-(2-(thiophen-2-ylmethylene)hydrazinyl)phthalazine hydrochloride–ethanol (1/1), C15H17ClN4OS
  40. Crystal structure of N,N-diethyl-5-bromo-3,4-dihydro-2,4-dioxopyrimidine-1(2H)-carboxamide, C9H12BrN3O3
  41. Crystal structure of 3-(2-(4-chlorophenyl)-3-hydroxy-3,3-diphenylpropyl)-1,1-dimethylurea, C24H25ClN2O2
  42. Crystal structure of 3-(4-chlorophenyl)-1,1-dimethylthiourea, C9H11ClN2S
  43. Crystal structure of 2-amino-4-(4-bromo-phenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C16H11BrN2O3
  44. Crystal structure of 4-(3,4-dimethyl-phenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester, C21H25NO3
  45. Crystal structure of (E)-2-({4-hydroxy-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]phenyl} methylidene)-1-indanone, C23H26N2O3
  46. Crystal structure of tripropylammonium 2′-carboxy-[1,1′-biphenyl]-2-carboxylate – [1,1′-biphenyl]-2,2′-dicarboxylic acid (2/1), C60H72N2O12
  47. Crystal structure of catena-poly-{aqua-[μ2-1,2-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′]-[μ2-4,4′-(dimethylsilanediyl)dibenzato-κ3O,O′:O′]nickel(II)}, C30H30N4NiO5Si
  48. The crystal structure of 1-(4-bromophenyl)-2-(4-(4-fluorophenyl)piperazin-1-yl)ethanol, C18H20BrFN2O1
  49. Crystal structure of trimethylammonium 4-((4-carboxyphenyl)sulfonyl)benzoate, C17H19NO6S
  50. Crystal structure of syn-2,4-di-o-tolylpentane-2,4-diol, C19H24O2
  51. Crystal structure of 2-[3,5-bis(trifluoromethyl)benzylsulfanyl]-5-(5-bromothiophen-2-yl)-1,3,4-oxadiazole, C15H7BrF6N2OS2
  52. Crystal structure of (E)-3-((naphthalen-1-ylimino)methyl)-4-nitrophenol, C17H12N2O3
  53. Crystal structure of 2-dichloromethyl-2-p-nitrophenyl-1,3-dioxolane, C10H9Cl2NO4
  54. Crystal structure of (1,4,8,11-tetraazacyclotetradecane)palladium(II) tetracyanopalladate(II), C14H24N8Pd2
  55. Crystal structure of 2-(4-oxo-2-thioxothiazolidin-3-yl)acetic acid monohydrate, C5H7NO4S2
  56. Crystal structure of a P4-bridged (η5-pentamethyl-cyclopentadienyl)(η5-adamantylcyclopentadienyl) titanium(III)complex, C50H66P4Ti2
  57. Crystal structure of cis-bis(2,2′-bipyrimidine-κ2N,N′)bis(thiocyanato-κN)nickel(II), C18H12N10NiS2
  58. Crystal structure of cis-bis(2,2′-bipyridine-κ2N,N′)dibromidomanganese(II), C20H16Br2MnN4
  59. Crystal structure of cis-bis(2,2′-bipyridine-κ2N,N′)bis(thiocyanato-κN)nickel(II), C22H16N6NiS2
  60. Crystal structure of trans-dibromido(1,4,8,11-tetraazacyclotetradecane)nickel(II), C10H24Br2N4Ni
  61. Crystal structure of cis-tetrabromidobis(pyridine-κN)platinum(IV), C10H10Br4N2Pt
  62. Crystal structure of (E)-5-((4-chlorophenyl)diazenyl)-2-(5-(4-fluorophenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole, C23H17ClFN5S2
  63. The crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetrachloridocobaltate(II) monohydrate, C10H18Cl4CoN2O
Heruntergeladen am 5.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0150/html
Button zum nach oben scrollen